LoginSignup
BTM

Biote

Stock
Stock
ISIN: US0906831039
Ticker: BTMD
US0906831039
BTMD

Price

Price

Frequently asked questions

What is Biote's market capitalization?

The market capitalization of Biote is $333.63M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Biote's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Biote is 29.41. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Biote?

Biote's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.209. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Biote's stock?

Currently, 5 analysts cover Biote's stock, with a consensus target price of $9.266. Analyst ratings provide insights into the stock's expected performance.

What is Biote's revenue over the trailing twelve months?

Over the trailing twelve months, Biote reported a revenue of $193.06M.

What is the EBITDA for Biote?

Biote's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $44.53M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Biote?

Biote has a free cash flow of $32.95M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Biote's stock?

The 5-year beta for Biote is 1.00. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Biote have, and what sector and industry does it belong to?

Biote employs approximately 194 people. It operates in the Industrials sector, specifically within the Business Services industry.

What is the free float of Biote's shares?

The free float of Biote is 23.67M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $333.63M

5Y beta

 1.00

EPS (TTM)

 $0.209

Free Float

 23.67M

P/E ratio (TTM)

 29.41

Revenue (TTM)

 $193.06M

EBITDA (TTM)

 $44.53M

Free Cashflow (TTM)

 $32.95M

Pricing

52W span
$3.654$8.44

Analyst Ratings

The price target is $9.266 and the stock is covered by 5 analysts.

Buy

5

Hold

0

Sell

0

Information

biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.

194

Business Services

Industrials

Identifier

ISIN

US0906831039

Primary Ticker

BTMD
Join the conversation
Sign upLogin